Why almost no good lab will test your peptide
The labs best equipped to test your peptide are the ones least able to accept it. Accreditation, certification and liability all bite the moment a private person asks for a result. That is not a scandal. It is how this market is built.
I did not start out trying to build a laboratory directory. I bought peptides from a vendor, paid for them, and got back something I could not identify. I wanted to know what was in the vial. I thought that would be simple: someone tests things for a living, I pay them, and they tell me.
It took me a long time to understand why almost nobody would do that. At some point, I stopped being angry at the laboratories, because the reason turned out not to be about them. This is what I found.
Almost every rule that makes a laboratory trustworthy also makes it unable to serve you. An accreditation only ever covers certain test methods, on certain materials. Certification kicks in the moment a lab tells a private person their result. A package from the post has no documented origin. And for many research peptides, the material you would measure against does not exist. Any one of these is enough on its own.
So the labs best equipped to test your vial are the ones least able to accept it. Once you understand why, you read a certificate differently.
An accreditation is a list, not a badge
ISO/IEC 17025 is the standard behind the words "accredited laboratory". Many people hear a seal that covers everything the lab does. That is not what it means. Each test method is accredited on its own. And always for one particular material. Specialists call that material the matrix.
A lab can be accredited to test finished pharmaceutical tablets. That does not make it accredited for a freeze-dried peptide powder of unknown origin. Different material, different entry. The lab can still run the analysis; the instrument does not care. But it may not call the result accredited. If it did, it would lend its reputation to work its accreditation never covered. What a lab is truly accredited for is written in its scope document. Not on its homepage.
The catch is not the testing. The catch is telling you
A good lab can measure your sample without any difficulty. The difficulty starts when it has to tell you the result. That gap explains more than anything else on this page.
In the United States, a law called CLIA governs which facilities may examine human specimens. It applies when the purpose is diagnosis, prevention, treatment or health assessment. Research laboratories are exempt. That exemption holds only as long as they do not report the result back to the tested person or their doctor. It falls away where the result could inform a treatment decision. Intentional violations are criminal offences.
Read that again. The analysis is not what is regulated. Giving you the answer is. And that is exactly what you want: to know what is in your vial. It is also what pulls the lab into a licensing regime it may not be in. A lab can quietly run your sample. It cannot quietly tell you the number.
A package with no history proves nothing
Serious analytical work depends on an unbroken record. It documents where a sample came from, and who handled it when. Specialists call it the chain of custody. Regulatory guidance is blunt about it: if a sample was not collected properly, the result should be thrown out.
An anonymous powder from the post has none of that. Nobody can attest what it is or where it came from. A result describes the powder in that tube. Nothing more. In front of a regulator or a court it carries no weight.
For many of these peptides, there is no ruler
To measure purity and confirm identity properly, a lab needs a comparison sample. Its composition is already established. This is called a certified reference material. It is the ruler the measurement is made with.
Approved peptides have one. Bivalirudin, desmopressin, exenatide, leuprolide and oxytocin, among others. For many research peptides, none is documented. Without a ruler, a lab can still report a number. It cannot stand behind it. Developing its own reference material would be possible. For a handful of retail samples, nobody does.
The only labs that can serve you are the ones with nothing to lose
Having nothing to lose is not an insult here, it is arithmetic. A lab with accreditation, certification, insurance and pharmaceutical clients puts all of it at risk - for one small retail order. It declines. A lab outside that system risks far less. It accepts.
So the labs that do take private samples are usually the ones without ISO/IEC 17025. This is not a hidden scandal. It is the structure of the market. And it means the usual shortcut leads nowhere. Almost everyone asks whether a lab is accredited. That is a question you never needed to ask.
What replaces accreditation is verifiability
Some labs print a report number and a unique key on every certificate. Anyone can look up that one report in the lab's own database. This is a different kind of assurance. The question is no longer: who vouches for this lab? It becomes: does the lab confirm this exact document to me, right now? Where formal accreditation cannot reach, this is the strongest signal a certificate can carry.
Why the honest lab is the one that loses
A real analysis costs money and instrument time. A forged certificate costs nothing. And nobody audits certificates of analysis. For unapproved substances there is no regulator whose job that would be.
The rest follows by itself. A vendor buys one genuine test. Then reuses that certificate for later batches that were never tested. A vendor's "in-house lab" turns out to be the vendor. A certificate carries the letterhead of a lab that does not exist. Each is cheaper than testing. And until recently, none of them could be checked. On the product page, the vendor who pays for testing looks exactly like the one who prints a document.
Only one thing breaks this open: confirmation from the issuer. Not the PDF the seller hands you. A report number you check with the lab that supposedly wrote it. Everything else is a claim.
What we can and cannot do for you
A missing accreditation is not proof of dishonesty. For a lab serving private individuals it is close to unavoidable. The more worrying case is a lab that claims an accreditation and cannot show it to you. Ask the question this market can answer instead: does the lab named on the document confirm the document?
This directory is built around that question. We audit laboratories and publish what we find. For every signal we name the source, its scope and the date. We try to give you an overview of a market that reveals almost nothing about itself.
Our assessment is not authoritative. We are not a regulator. We certify nobody. And we can be wrong. Where a signal ends, we say so. What we offer is an attempt at an honest overview where otherwise there is none. Every judgement we make, you can trace back to the evidence behind it.
I can build this because I have the means to do it: I run software for a living, the research runs on agents I wrote, and nobody pays me for a result. I get things wrong. When that happens, I would rather you catch the mistake with the sources in front of you than believe me because I sounded certain.
What came out of the same trip through the strange country of the peptide trade, you will find at peptipedia.cc - the ad-free peptide knowledge base. I built that one first. This directory is the part that was still missing.
- Samuel
Sources
- 42 CFR Part 493 - Laboratory Requirements (CLIA)
- CDC - Clinical Laboratory Improvement Amendments (CLIA)
- FDA - Clinical Laboratory Improvement Amendments (CLIA), IVD regulatory assistance
- FDA - In Vitro Diagnostic Device Labeling Requirements (21 CFR 809)
- FDA Guidance - Distribution of In Vitro Diagnostic Products Labeled for Research Use Only
- ANAB - Scope of accreditation requirements
- FDA - Investigations Operations Manual, sample collection and chain of custody
- Reference standards for peptide analysis (PMC)
- Certified reference materials for therapeutic peptides (PMC)
- How peptide companies trigger intended-use violations (objective intent doctrine)